These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37959744)

  • 21. Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
    de Souza AS; de Souza RF; Guzzo CR
    J Biomol Struct Dyn; 2022; 40(21):11339-11356. PubMed ID: 34370631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.
    Crisan L; Istrate D; Bora A; Pacureanu L
    Mol Divers; 2021 Aug; 25(3):1775-1794. PubMed ID: 33237524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-Based Virtual Screening, Molecular Docking, Molecular Dynamics, and MM-PBSA Calculations towards the Identification of Potential Novel Ricin Inhibitors.
    Botelho FD; Dos Santos MC; Gonçalves ADS; Kuca K; Valis M; LaPlante SR; França TCC; de Almeida JSFD
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33256167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel potential β-N-acetyl-D-hexosaminidase inhibitors by virtual screening, molecular dynamics simulation and MM-PBSA calculations.
    Liu J; Liu M; Yao Y; Wang J; Li Y; Li G; Wang Y
    Int J Mol Sci; 2012; 13(4):4545-4563. PubMed ID: 22605995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach.
    Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Asdaq SMB; Eltaib L; Kamal M; Alshammari ABH; Alshammari AMA; Alshehri A
    J Infect Public Health; 2023 Apr; 16(4):554-572. PubMed ID: 36812878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.
    Chen C; Zhou XH; Cheng W; Peng YF; Yu QM; Tan XD
    J Mol Model; 2022 Sep; 28(10):336. PubMed ID: 36180796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel Glutaminase allosteric inhibitors through drug repurposing and comparative MMGB/PBSA and molecular dynamics simulation.
    Yousaf R; Navid A; Azam SS
    Comput Biol Med; 2022 Jul; 146():105669. PubMed ID: 35654625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of MM-PBSA Methods in Virtual Screening.
    Poli G; Granchi C; Rizzolio F; Tuccinardi T
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology Modeling,
    Sakyi PO; Broni E; Amewu RK; Miller WA; Wilson MD; Kwofie SK
    Front Cell Infect Microbiol; 2022; 12():859981. PubMed ID: 35719359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying natural product inhibitors against CDK9 enzyme via combined multicomplex-based pharmacophore modeling, interaction studies and molecular dynamics simulations.
    Ghosh A; Mukherjee S; Jha PC; Manhas A
    Comput Biol Med; 2023 Jul; 161():107055. PubMed ID: 37244149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies.
    Bhujbal SP; He W; Hah JM
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
    Chahal V; Kakkar R
    J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel potential ricin inhibitors by virtual screening, molecular docking, molecular dynamics and MM-PBSA calculations: a drug repurposing approach.
    Botelho FD; Santos MC; Gonçalves AS; França TCC; LaPlante SR; de Almeida JSFD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5309-5319. PubMed ID: 33410376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology modeling, docking and structure-based virtual screening for new inhibitor identification of
    Panda SK; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2020 Apr; 38(7):1887-1902. PubMed ID: 31179839
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
    Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
    J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
    Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.